Asia Fresh News

Asia Fresh Stories

Archive for March 11th, 2015

New Distribution Agreement Extends Wireless Module Choices at RS Components and Allied Electronics

leave a comment »

-High-performing Wi-Fi and Bluetooth modules accelerate time to market for Internet of Things, audio-visual and general-purpose applications

HONG KONG /PRNewswire/ — RS Components (RS), the trading brands of Electrocomponents plc (LSE:ECM), the global distributor for engineers, have introduced an exciting new range of wireless modules and system-in-package devices, under an exclusive distribution agreement with Jorjin Technologies Inc. ofTaiwan.

New distribution agreement extends wireless module choices at RS Components and Allied Electronics
New distribution agreement extends wireless module choices at RS Components and Allied Electronics

The Jorjin portfolio enables RS customers to accelerate time to market and deliver competitively priced Internet of Things (IoT), audio, and other applications leveraging Bluetooth® Smart and Wi-Fi® connectivity.

“Appointing RS opens an exciting new channel for Jorjin, and represents a tremendous opportunity to increase our brand recognition in world markets,” said Chris Bryson, Vice President Sales and Marketing at Jorjin. “This agreement introduces us to a large customer base of technology innovators addressing diverse markets for our wireless solutions, and allows us to take advantage of the know-how and energy that RS bring to its activities.”

“Partnering with Jorjin significantly extends our portfolio of wireless solutions, which covers all of the major communication technologies and comprises a wide range of high-performing products that deliver excellent value for customers,” said Jon Boxall, Global Head of Semiconductors at Electrocomponents. “We are looking forward to working successfully with Chris and the team at Jorjin to grow sales year on year.”

RS is initially adding six Jorjin wireless modules to their portfolios, including the latest WA6800-00 25mmx50mm audio-visual wireless module with USB and wireless DLNA connectivity, and the associated WA6800-C0 baseboard. Also available are WG7801-D0 and WG7831-D0 Wi-Fi and Wi-Fi/Bluetooth SiP modules, WG1400-00 module with Wi-Fi and IoT technologies integrated, WG7831-DELFA Wi-Fi/Bluetooth module for general-purpose applications, and optional evaluation boards where applicable.  These products are available from RS across EMEA and selected APAC countries, and in North America via Allied Electronics.

About RS Components

RS Components and Allied Electronics are the trading brands of Electrocomponents plc, the global distributor for engineers. With operations in 32 countries, we offer around 500,000 products through the internet, catalogues and at trade counters to over one million customers, shipping more than 44,000 parcels a day. Our products, sourced from 2,500 leading suppliers, include semiconductors, interconnect, passives and electromechanical, automation and control, electrical, test and measurement, tools and consumables.

Electrocomponents is listed on the London Stock Exchange and in the last financial year ended 31 March 2014had revenues of GBP1.27bn.

For more information, please visit the website at

RS Components
Tan Soo Chun
Public Relations Manager – Asia Pacific
Telephone: +65-6391-5745

Edelman Public Relations (Singapore)
Yvette Yeo
Telephone: +65-6347-2355

Further information is available via these links:

Twitter: @RSComponents; @alliedelec; @designsparkRS

RS Components on Linkedin

RS Components on Weibo

Relevant Links:

Electrocomponents plc

RS Components


Photo –
Logo –

Source: RS Components Singapore

Related stocks: LSE:ECM OTC-PINK:EENEY

Written by asiafreshnews

March 11, 2015 at 6:27 pm

Posted in Uncategorized

Zwilling J.A. Henckels Selects IBS Sales & Operations Planning and IBS Analytics Powered by QlikView to Streamline Complex Supply Chain

leave a comment »

— Knife Manufacturer Realizes One Integrated View, Capability to Monitor Key Supply Chain Metrics in Tightly Integrated Closed-loop System

FOLSOM, Calif., March 10, 2015 /PRNewswire/ — International Business Systems (IBS), a global leading integrated ERP and supply chain solution provider, today announced that Zwilling J.A. Henckels has selected IBS Sales & Operations Planning (IBS S&OP) software and IBS Analytics powered by QlikView to manage its complex supply chain.

Logo –

IBS is the trusted industry leader of ERP and WMS distribution software, preferred for consistently improving operational efficiencies and business performance for mid-market companies challenged by the complexities of managing distribution.

IBS’ partnership with Qlik, a leader in user-driven Business Intelligence (BI), adds robust BI capabilities. IBS Analytics powered by QlikView is integrated into the IBS software suite of products, serving customers in key verticals like pharmaceuticals, food & beverage, automotive aftermarkets, 3PL and wholesale distribution.

“IBS S&OP provides one integrated view, monitors key supply chain metrics, and strikes a balance between customer service and inventory levels,” said Tim Conroy, General Manager of the Americas, IBS. “The IBS S&OP platform and IBS Analytics powered by QlikView will help Zwilling J.A. Henckels work from a common business plan and connect key business data, which drive competitive advantage.”

Zwilling J.A. Henckels is a global knife manufacturer based in New York. With 50 branded stores in 100 countries, it is one of the largest and oldest manufacturers of kitchen knives, scissors, cookware and flatware.

“Our global presence adds complexity to the supply chain, but our implementation of IBS S&OP and business intelligence tools will complement our current use of IBS Enterprise,” said John Henkel, CFO at Zwilling J.A. Henckels. “Our brand is built upon stellar products delivered in a timely fashion to customers around the world. IBS software will help us streamline inventory, manage stockroom levels and order cycles, and improve our overall supply chain.”

IBS applications deliver benefits such as lower IT cost through fixed monthly fees, reduced business risk, faster time to value and greater flexibility – combined with the advanced functionality of the IBS industry-leading ERPand Supply Chain solutions.

About IBS
International Business Systems (IBS) is a leading global integrated ERP and supply chain distribution software solution provider. For more than 35 years, we have helped customers such as WORLDPAC, Fidelitone, Associated Pharmacies, Inc., GILLIG, Zwilling J.A. Henckels, Miele Inc., Tri Literal LLC, Mighty Auto Parts, Victory Packaging Inc. and many more streamline, automate and accelerate their distribution network processes, and drive profitability and efficiency.

For more information, please visit

Source: International Business Systems
Related Links:

Written by asiafreshnews

March 11, 2015 at 6:10 pm

Posted in Uncategorized

Museum Dr. Guislain and Janssen Research & Development, LLC Issue Global Call for Nominations for 2015 Dr. Guislain “Breaking the Chains of Stigma” Award

leave a comment »

GHENT, Belgium, March 10, 2015 /PRNewswire/ — The Museum Dr. Guislain in Ghent, Belgium, and Janssen Research & Development, LLC (“Janssen”) today announced they are seeking nominations for the fourth annual Dr. Guislain “Breaking the Chains of Stigma” Award. The award honours an individual, project or organisation that has made an exceptional contribution to reduce stigma associated with mental illness.


Nominations from people and organisations across the globe can be submitted at, and will be accepted until 31 March 2015. A $50,000 prize will be awarded to the individual or group receiving the award, which must be used toward further work to reduce societal stigma about mental illness.

The winning individual, project or organisation will be determined by an independent selection committee of international advocates and renowned authorities in the field of mental health, and honoured at a ceremony on 8 October 2015 in Ghent, Belgium.

Museum Dr. Guislain and Janssen jointly sponsor the award, with funding provided by Janssen. Both organisations have a rich heritage and long-standing involvement in the field of mental illness research, treatment and education.

About the Dr. Guislain “Breaking the Chains of Stigma” Award

Individuals, organisations or projects from around the world that have made an exceptional contribution in dealing with, or promoting the awareness of, mental health care are eligible to receive the Dr. Guislain “Breaking the Chains of Stigma” Award. The Award is given to an individual(s), organisation or project that:

  • has made an exceptional contribution to mental healthcare in the broadest sense on a cultural and/or social level;
  • has provided a genuine contribution to decreasing stigma around mental health conditions;
  • has promoted attention for mental health care;
  • and has done all this with passion, creativity and innovation.
Source: Museum Dr. Guislain

Written by asiafreshnews

March 11, 2015 at 5:51 pm

Posted in Uncategorized

Spring Professional, a Division of the Adecco Group, Selects Talent Rover for Recruitment Solution

leave a comment »

— Adecco Group Subsidiary Chooses Talent Rover to Power Staffing and Recruitment Across Asia

SAN FRANCISCO, March 10, 2015 /PRNewswire/ — Talent Rover, provider of cloud-based software built for managing the entire staffing and recruitment workflow, announced today that Spring Professional, a wholly owned subsidiary of the Adecco Group, the world’s largest human resources organization, has selected Talent Rover to power its operations across Asia.

An international firm specializing in information technology, engineering and property and construction recruitment, Spring Professional focuses exclusively on the recruitment of middle to senior level management and specialists. Since launching regionally in March 2013, Spring Professional Asia has established offices and teams of recruiters in mainland China, Hong Kong, Malaysia, Singapore, South Korea, Taiwan, Thailand andJapan.

With multiple languages, currencies and labour regulations to contend with, Spring Professional needed a recruitment solution that could meet local requirements while unifying the company through a single CRM, ATS and workflow. Given the company’s reach, a cloud-based solution was deemed crucial for minimizing IT costs and providing recruiters with a reliable user experience across Spring Professional’s nine offices in Asia.

Talent Rover met Spring Professional’s demand for a software solution that could support rapid regional expansion. Talent Rover’s intuitive user experience and full functionality from any mobile device made the solution stand out from the competition. Spring Professional’s executives also saw opportunities to regularly analyse data and improve strategy using Talent Rover’s simple drag-and-drop report builders. By consolidating nearly every tool a recruiter needs into a single software solution, Talent Rover showed the highest potential to improve performance while saving time and costs.

“We wanted a recruitment software that would give our recruiters a competitive edge, and Talent Rover presented a solution that we felt could work well across the Asia region,” said Serge Shine, Managing Director, Spring Professional Asia (ex-Japan). “Our leadership team is excited to have recruitment technology that can keep up with our growth across Asia, and match our drive to provide clients and candidates with outstanding service.”

“We are very excited to welcome Spring Professional to Talent Rover, and we are committed to supporting their success throughout Asia-Pacific,” said Brandon Metcalf, COO of Talent Rover. “Our cloud-based solution is uniquely capable of powering recruitment anywhere in the world, and the APAC region has become a prime focus for our company. Our Hong Kong office will be dedicated to serving clients throughout the region and fostering the growth of the recruitment industry in the world’s most dynamic economies.”

About Spring Professional
Spring Professional is an international firm specialising in information technology, engineering and property & construction recruitment across the Asia region, with offices in mainland China, Hong Kong, Japan, Malaysia,Singapore, South Korea, Taiwan and Thailand.

Spring Professional is a wholly-owned subsidiary of the Adecco Group. Based in Zurich, Switzerland, the Adecco Group is the world’s leading provider of HR solutions. With over 32,000 FTE employees and more than 5,100 branches, in over 60 countries and territories around the world, the Adecco Group offers a wide variety of services, connecting more than 650,000 associates with clients every day. The services offered fall into the broad categories of temporary staffing, permanent placement, career transition and talent development, as well as outsourcing and consulting. The Adecco Group is a Fortune Global 500 company.

Adecco Group’s holding company, Adecco S.A. is registered in Switzerland and listed on the SIX Swiss Exchange.

About Talent Rover
Talent Rover makes staffing and recruitment software the way it should be: simple, mobile, devoted to increasing efficiency and profitability across the entire workflow. Built by recruiters for recruiters, Talent Rover eliminates tedious processes and repeat data entry so that recruiters can spend less time dealing with technology and more time making placements. The software combines sales (CRM), recruitment (ATS), human resources (HRIS) and back office in one cloud-based solution. Talent Rover also gives firms a competitive edge with real-time dashboards, recruitment-specific software integrations and the global capabilities of the Salesforce Platform.

Power any size firm, anywhere in the world. Make fewer clicks and more placements. Learn more

Source: Talent Rover

Written by asiafreshnews

March 11, 2015 at 5:30 pm

Posted in Uncategorized

Easter Holiday Plan = City Hopping with Dorsett

leave a comment »

KUALA LUMPUR, Malaysia, March 10, 2015 /PRNewswire/ — This Spring, embark on an escapade and experience Asian inspired hospitality at an attractive Best Available Rates with hotels under Dorsett Hospitality International across Hong Kong, China, Singapore, Malaysia and latest in London.

Promotion booking period starts from February 26 to April 12, 2015 (inclusive); staying period from March 29 to April 12, 2015 (inclusive). Promo Code: ES2015.

Book your stays* now at now!

*Terms & Conditions apply

Offer is subject to availability.
Offer is only applicable for reservation made at “EASTER SPECIAL DEAL” rate between the booking period stated above. It is not applicable with any other rate and promotional package/offer.
Respective hotel cancellation policy applies.
Rates quoted are subject to prevailing taxes.
Offer is not valid for group bookings. (5 rooms or more)
Rates are subject to seasonality changes at the time of checking availability and at the time of booking.

United Kingdom

Dorsett Shepherds Bush, West London

Where heritage meets contemporary elegance. Dorsett Shepherds Bush, the perfect hotel choice for both business and leisure travellers offers stylish and comfortable accommodation for the most discerning guests to enjoy, relax, party and refresh. The 8-storey hotel with 317 rooms boasts modern architecture and design; originally The Pavilion is a Grade II listed building, which overlooks Shepherds Bush Green, retaining the building’s historic facade. The hotel offers 2 restaurants, Jin bar and a spa.


Dorsett Singapore

Dorsett Singapore, the perfect hotel choice for both business and leisure travellers offers stylish and comfortable accommodation for the most discerning guests to enjoy, relax and refresh. The 10-storey hotel boasts of modern architecture and design; and is cladded with a full glass building façade to present a refreshing landmark that seeks to harmonise with the heritage backdrop of Chinatown precinct.

Hong Kong

Lan Kwai Fong Hotel @Kau U Fong, Central

An award-winning boutique hotel in Central Hong Kong, Lan Kwai Fong@Kau U Fong is all about stylish and comfortable accommodation with convenient access to the vibrant hubs of Lan Kwai Fong and SoHo areas of Hong Kong.

Dorsett Tsuen Wan

Situated in the bustling district, Dorsett Tsuen Wan offers a convenient location for both business and leisure travellers with easy access to Hong Kong’s major shopping and dining hubs like Tsim Sha Tsui and Mong Kok.

Dorsett Kwun Tong

Situated at the heart of Kowloon East, a 8-minute walk to the MTR station and surrounded by apm, MegaBox, Telford Plaza, Emax and other shopping malls.

Dorsett Mongkok

Dorsett Mongkok, a midscale hotel in Kowloon holds true to its service philosophy of ‘Beyond thoughtful. Anytime. Everywhere’ and strives to ensure a memorable stay with thoughtful attention and unobtrusive service.

Cosmopolitan Hotel, Causeway Bay/Wanchai

A stylish, four-star Hong Kong hotel, Cosmopolitan Hotel Hong Kong is conveniently located midway between Causeway Bay’s major entertainment and shopping attractions and the commercial district of Wan Chai.

Cosmo Hotel, Causeway Bay/Wanchai

One of the most stylish Causeway Bay hotels with a voguish touch of design, Cosmo Hotel Hong Kong, a great hit of Hong Kong hotel reservations, welcomes you with a kind of stay totally beyond expectation.

Silka Seaview, Yau Ma Tei

Silka Seaview, Hong Kong is situated in Yau Ma Tei, just a footstep away from Yau Ma Tei MTR Station and right next to the Temple Street Market and Jade Market. With 268 well-equipped guestrooms, the hotel also provides FREE WiFi for seamless connectivity.

Silka West Kowloon, Mongkok

Silka West Kowloon Hotel Hong Kong is a value hotel situated in Tai Kok Tsui, a booming new city in Kowloon. The hotel provides 141 comfortable and affordable guestrooms in a convenient location.

Silka Far East, Tsuen Wan

Silka Far East, Hong Kong is a value hotel located in Tsuen Wan, a bustling bay in Hong Kong. With 240 modern rooms, Silka Far East is a comfortable and safe hotel for budget business and leisure travellers.


Dorsett Kuala Lumpur

At the heart of Kuala Lumpur’s Golden Triangle, Dorsett Kuala Lumpur is surrounded by the city’s busiest shopping malls, entertainment centres and tourists attractions.

Silka Cheras, Kuala Lumpur

One of the group’s newest hotels, Silka Cheras Kuala Lumpur is centrally located in Cheras, a bustling suburb of Kuala Lumpur and next to the exciting shopping hub of Cheras Sentral Mall. Comfortable, hassle-free and offering great value, this hotel epitomises the true essence of Asian inspired hospitality.

Silka Maytower, Kuala Lumpur

With its central location, Silka Maytower Kuala Lumpur is the ideal choice for both business and leisure travellers; offering convenient access to businesses as well as places of interests ranging from shopping, entertainment and dining choices within the city.

Silka Johor Bahru

Silka Johor Bahru features well-appointed rooms that are suitable for value-savvy families and business travellers. Recreational facilities include a sparkling free-form swimming pool and a well-appointed gymnasium as well as tennis and squash courts.

Dorsett Grand Subang

Situated in the commercial hub of Subang Jaya, Dorsett Grand Subang is an upscale urban resort offering tastefully furnished guestrooms and suites as well as a host of business, dining and recreational facilities to cater to the needs of its discerning guests.

Dorsett Grand Labuan

The premier hotel in Labuan, the Dorsett Grand Labuan brings out the best of what Labuan Island has to offer. The hotel is only minutes away from the Labuan Airport and a short distance from its bustling town centre. With an international buffet spread and wide array of ala-carte dining, a sports lounge for guests to catch their favourite sports coverage, and a bar offering live entertainment at night, Dorsett Grand Labuan truly inspires!


Dorsett Grand Chengdu

Next to the popular historical Luoma Market area in Chengdu, Dorsett Grand Chengdu is an upscale hotel that provides an intimate and luxurious environment for guests complemented by a full range of modern amenities.

Lushan Resort

Situated in the heart of Tian Mu hot spring village and with the magnificent Lushan Mountain as its backdrop, Lushan Resort provides an unforgettable escapade for the body, mind and soul with its range of facilities including rejuvenating experiences of its outdoor hot spring pools.

Dorsett Shanghai

Located in Pudong district, Dorsett Shanghai overlooks the picturesque Century Park and minutes away from the Shanghai new international expo centre. With the Metro Line station adjacent to the hotel, the hotel with its comfortably furnished guestrooms and suites; proves to be the perfect hotel choice for both business and leisure travellers.

Dorsett Wuhan

Dorsett Wuhan is situated in the heart of downtown Wuhan within the famous pedestrian boulevard of Jianghan Road. With the convenient transportation network of the Metro Line 1 and 2 at Xunlimen Station, travellers can easily access Wuhan’s major attractions and commercial districts.

About Dorsett Hospitality International Limited

Headquartered in Hong Kong, Dorsett Hospitality International (HKEx Stock Code 2266), is a spinoff from Far East Consortium Limited. With three brands under its umbrella ….the upscale and midscale Dorsett Hotels & Resorts and d.Collection comprising a range of charismatic boutique hotels; and the value-led Silka Hotels; the group currently owns and manages 30 hotels in China, Hong Kong, Singapore, Malaysia and United Kingdom; with eight more openings within the next two years in China, Hong Kong, Malaysia and United Kingdom. For more information on Dorsett Hospitality International, visit:
Source: Dorsett Hospitality International

Written by asiafreshnews

March 11, 2015 at 4:33 pm

Posted in Uncategorized

HLA Pays Tribute To Its Million Dollar Round Table Achievers

leave a comment »

KUALA LUMPUR, Malaysia, March 10, 2015 /PRNewswire/ — Hong Leong Assurance (HLA), the country’s fastest growing life insurance company, is proud to host an event to celebrate the achievers of the 2015 Million Dollar Round Table (MDRT) recognition benchmark.

A new historical record for HLA has been achieved with three (3) Top of the Table (TOT) and five (5) Court of the Table (COT). The TOT is awarded to agents who have achieved 6 times the base MDRT production requirement, while the COT is awarded to agents who have achieved 3 times the MDRT base production requirement. A grand total of 119 agents qualified for the MDRT recognition benchmark.

The Company recognised HLA’s MDRT benchmark qualifiers during the 2-day MDRT training-cum-celebration at The Haven, Ipoh. Agency leaders and members attended this event, which was held to honour the MDRT recognition benchmark qualifiers and also celebrate their achievements.

This year, there were a total of 3 TOT qualifiers. May Lee Sue Wee is no stranger to the award, as this is the 13th time that she is qualifying for TOT while also being a TOT Qualifying And Life Member. Previously, she was certified by MDRT USA and the Malaysian Book of Records as the 1st in Malaysia and the 4th in South-East Asia to achieve TOT for the 10th time.

Among HLA’s TOT qualifiers, the highest qualifying First Year Premium (FYP) was attained by Jessie Wong Siaw Puie, who achieved total premiums of over RM 5 million in a short span of 7 months as an agent. The second highest qualifying FYP was attained by Pauline How Sze Wen, who boasts an impressive 3 times MDRT and 1 time COT in addition to qualifying for this year’s TOT.

There were also a total of 5 COT qualifiers, namely Eileen Looi Siew Lan, Cruz Wong Chung Hua, Julia Hung Siew Lim, Asroma binti Mat Ali, and Arianna Tan Su Vui. These agents have left a vivid impression on the industry by attaining this achievement with HLA through their impressive FYPs.

During the awards ceremony, Loh Guat Lan, Group Managing Director and Chief Executive Officer of HLA said, “Congratulations to all the MDRT benchmark achievers! We are proud that our agents have gained worldwide recognition. Their perseverance, hard work, and determination have resulted in them attaining this internationally acclaimed achievement. This achievement represents the highest level of excellence amongst the professionals of the industry who believe in providing their clients with the best financial services.”

“In order to instill a culture of professionalism and raise the core competencies of our agents, we have provided them with enhanced training that helps them to develop a solid foundation in our business. Through our personal development programmes, we are confident that our agents are equipped with the skills to become tomorrow’s leaders.”

“This passion for cultivating success in people has proven itself over time, as we have one of the largest agency forces in the country with over 11,000 in-force agents. We are the leading local insurer in Malaysia, with our total gross premiums at RM 2.3 billion for the financial year 2013/2014,” she added.

About Hong Leong Assurance Berhad

Hong Leong Assurance Berhad (HLA) is one of the largest insurance companies in Malaysia. It is a well-established and respected Malaysian brand offering financial planning and protection solutions to meet the various needs of Malaysians at different stages of their lives. Commitment to the customer is the key to HLA’s success, where service is provided through a large network of branches, agents and brokers throughout the country as well as Bancassurance and alternative distribution channels.

HLA is one of Malaysia’s leading domestic brands for financial planning and protection solutions, specialising in Life Insurance products and services.
Source: Hong Leong Assurance

Written by asiafreshnews

March 11, 2015 at 3:28 pm

Posted in Uncategorized

Takeda Hosts Investor Briefing on its Global Leadership in Gastroenterology

leave a comment »

NEW YORK /PRNewswire/ — Takeda Pharmaceutical Company Limited (“Takeda”) today held a briefing for investors and analysts in New York, discussing the company’s gastroenterology (GI) therapeutic area.

Gastroenterology is one of Takeda’s core therapeutic areas. With a range of standard treatments and a turnover of ¥299bn (FY13), Takeda is a global leader in the field. The company presented its strategy to further expand, highlighting the global launch of Entyvio® (vedolizumab), the Japanese launch of Takecab (vonoprazan) and enhanced research and development activities.

Slides from today’s briefing and additional information about Takeda is available through its corporate website at

About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.

Source: Takeda Pharmaceutical Company Limited
Related Links:

Written by asiafreshnews

March 11, 2015 at 3:24 pm

Posted in Uncategorized

Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial

leave a comment »

OSAKA, Japan /PRNewswire/ — Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptINvs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) cardiovascular (CV) safety outcomes trial was published in The Lancet. An analysis of data from the study showed that in patients with Type 2 diabetes and recent acute coronary syndrome (ACS), dipeptidyl peptidase 4 inhibitor (DPP4i) alogliptin compared to placebo did not increase the risk of heart failure (HF) outcomes. Alogliptin (n=201, 7.4%) compared with placebo (n=201, 7.5%) had no effect on the extended exploratory post hoc composite endpoint of CV death and hospitalized heart failure (HHF) (HR=1.00, 95% CI, 0.82, 1.21). Patients with a history of HF prior to randomization had a higher risk of HF outcomes in EXAMINE. The sub-analysis showed that the risk of the composite of CV death and HHF was not increased with alogliptin (n=107, 13.9%) compared with placebo (n=120, 15.7%) (HR=0.90, 95% CI, 0.70, 1.17). In patients without a history of HF at baseline, there was also no increased risk of the composite endpoint of CV death and HHF for alogliptin (HR=1.14 [95% CI 0.85-1.54], p=0.337) versus placebo, although there was in this sub group of patients a small absolute increase in HHF for alogliptin versus placebo (0.9%).

Alogliptin is the first DPP-4i to report out results on CV safety outcomes in Type 2 diabetes patients that are at high risk due to recent ACS. Heart disease, or cardiovascular disease (CVD), is the leading cause of morbidity and mortality in patients with Type 2 diabetes, and is responsible for between 50 and 80 percent of deaths in people with diabetes.

“Patients with diabetes are at significantly higher risk of having heart disease or suffering a stroke, and it is critical that diabetes treatments adequately manage glucose levels without adversely affecting cardiovascular outcomes, such as hospitalized heart failure and cardiac death,” said Faiez Zannad, MD, Professor of Therapeutics and Cardiology, Institut Lorrain du Coeur et des Vaisseaux, Centre d’Investigation Clinique Inserm, in France. “The publication of these post hoc analyses of data from EXAMINE is an opportunity to share findings that alogliptin compared with placebo did not increase the composite rate of cardiovascular mortality and hospitalized heart failure in this high risk population of patients with diabetes.”

The EXAMINE trial was designed to evaluate CV safety following treatment with alogliptin in addition to standard of care, versus placebo in addition to standard of care, in patients with Type 2 diabetes and a recent ACS. The EXAMINE trial’s primary composite endpoint (CV death, nonfatal myocardial infarction and nonfatal stroke) established non-inferiority of alogliptin compared to placebo in addition to standard of care, showing no increase in CV risk in a Type 2 diabetes patient population at high risk for CV events.

For the present study published in The Lancet, HF outcomes by quartile of baseline brain natriuretic peptide (BNP), as well as assessments of changes of N-Terminal proBNP (NT-proBNP) from baseline to six months were investigated. Patients in the highest quartile of baseline BNP were at the highest risk of HF outcomes; however, the risk of the composite endpoint of CV death and HHF was not increased with alogliptin (n=120, 17.5%) compared with placebo (n=121, 19.4%) (HR=0.90, 95% CI, 0.70, 1.16). Consistent with these outcomes, the change from baseline to 6 months for NT-proBNP was not different between alogliptin and placebo in this subgroup or in the overall study population.

About the EXAMINE Trial
EXAMINE randomized 5,380 patients in 49 countries with Type 2 diabetes with an ACS within the previous 15-90 days. The EXAMINE primary endpoint of non-inferiority compared to placebo in addition to standard of care was met, showing no increase in CV risk in a Type 2 diabetes patient population at high risk for CV events based on the primary composite endpoint of CV death, nonfatal myocardial infarction and nonfatal stroke. The primary endpoint occurred at similar rates in the alogliptin and placebo groups (in 11.3 percent of patients vs. 11.8 percent of patients during a median follow-up period of 18 months; HR, 0.96; upper boundary of the one-sided repeated CI, 1.16).

In the alogliptin group, 71.4 percent of patients received 25 mg, 25.7 percent received 12.5 mg, and 2.9 percent received 6.25 mg daily. Alogliptin doses were adjusted according to renal function: estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease formula > 60 ml/min/1.73 m2, 25 mg daily; < 60 ml/min/1.73 m2 but > 30 ml/min/1.73 m2, 12.5 mg daily; and < 30 ml/min/1.73 m2, 6.25 mg daily. Premature discontinuation of the study drug was similar in the alogliptin and placebo groups (20.9 percent of patients vs. 22.6 percent). The median duration of exposure to study drug was 533 days (interquartile range, 280 to 751 days). By the end of the study, the mean change from baseline in HbA1c was -0.33 percent and 0.03 percent in the alogliptin and placebo groups respectively, and the least square means difference in HbA1c between alogliptin and placebo was -0.36 percent (95 percent CI, -0.43, -0.28, p<0.001). In the analysis of the components of the primary endpoint, the hazard ratios were consistent with the overall result. Hazard ratios for death from any cause and CV death were consistent with the primary composite endpoint.

Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration’s (FDA) 2008 Guidance, titled “Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes,” for all new Type 2 diabetes treatments.

About Alogliptin
Alogliptin is a DPP-4i for the treatment of Type 2 diabetes in adults as an adjunct to diet and exercise. DPP-4is are designed to slow the inactivation of incretin hormones GLP-1 and GIP. As a result, an increased amount of active incretins enables the pancreas to secrete insulin in a glucose-dependent manner, thereby assisting in the management of blood glucose levels.

Alogliptin is approved as a monotherapy and also in fixed-dose combination (FDC) with pioglitazone and metformin HCl for the treatment of Type 2 diabetes in adults as adjuncts to diet and exercise. These therapies are not for treatment of Type 1 diabetes or diabetic ketoacidosis.

Alogliptin is available in many markets across Australia, China, Europe, Japan, Mexico, South Korea and the U.S.

Alogliptin is indicated in adults aged 18 years and older with Type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.

Important Safety Information

  • ALOGLIPTIN is contraindicated in patients with a history of serious hypersensitivity reaction to alogliptin-containing products such as anaphylaxis, angioedema, or severe cutaneous adverse reactions.
  • Acute pancreatitis: There have been post marketing reports of acute pancreatitis. If pancreatitis is suspected, promptly discontinue ALOGLIPTIN.
  • Hypersensitivity: Hypersensitivity reactions, including anaphylactic reactions, angioedema and exfoliative skin conditions including Stevens-Johnson syndrome have been observed for DPP-4 inhibitors. In clinical studies of alogliptin, anaphylactic reactions were reported with a low incidence.
  • Hepatic effects: Post marketing reports of hepatic failure, sometimes fatal. Causality cannot be excluded. Baseline liver test panel is recommended. If liver injury is detected, promptly interrupt ALOGLIPTIN and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart ALOGLIPTIN if liver injury is confirmed and no alternative etiology can be found.
  • Cardiac failure: Experience of ALOGLIPTIN use in clinical trials in patients with congestive heart failure of New York Heart Association (NYHA) functional class III and IV is limited and caution is warranted in these patients.
  • Hypoglycemia: Insulin and insulin secretagogues are known to cause hypoglycemia. A lower dose of the insulin or insulin secretagogue may be required to minimize the risk when used in combination with ALOGLIPTIN.
  • Most common adverse reactions: pooled phase 3 controlled studies (>1/10 frequency) with ALOGLIPTIN:  Upper respiratory infection, nasopharyngitis, headache, abdominal pain, gastroesophageal reflux disease, pruritis, and rash.

Please see local prescribing information for ALOGLIPTIN.

About Takeda’s Diabetes Business
Takeda’s heritage in diabetes globally includes significant contributions towards scientific discovery and exchange, starting with the discovery of the thiazolidinedione (TZD) pioglitazone, the more recent developments of alogliptin and the fixed-dose combinations (FDC) alogliptin and pioglitazone, and alogliptin and metformin HCl. The company’s strong, diverse diabetes portfolio and available medications mark important milestones in Takeda’s ongoing commitment to advancing patient care and helping to meet the individual needs of this growing patient population.

About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.

Additional information about Takeda is available through its corporate website,

Elissa J. Johnsen
Takeda Pharmaceuticals

Takeda Pharmaceutical Company Limited
Corporate Communications Dept.
Tel: +81-3-3278-2037

Source: Takeda Pharmaceutical Company Limited
Related Links:

Written by asiafreshnews

March 11, 2015 at 3:19 pm

Posted in Uncategorized

Columbus Council on World Affairs Honors Commercial Vehicle Group as the 2015 International Company of the Year

leave a comment »

NEW ALBANY, Ohio /PRNewswire/ — Commercial Vehicle Group, Inc. (the “Company”) (Nasdaq: CVGI) today announced that on March 3, 2015, the Columbus Council on World Affairs honored Commercial Vehicle Group (“CVG”) as the 2015 International Company of the Year, at a luncheon that marked the Council’s 40th anniversary. The Council recognizes a local company each year for its leadership in bridging the central Ohio community with the global economy and raising awareness of issues, such as education and trade, which have both an international and local impact. More than 600 business, civic and academic leaders joined the Council in honoring CVG.

CVG, headquartered in New Albany, Ohio, is a leader in the development, manufacturing and fulfillment of integrated system solutions for the medium- and heavy-duty truck, bus, construction, military, agriculture and specialty markets. CVG employs nearly 7,000 people globally and has manufacturing operations in the United States, Australia, China, Czech Republic, India, Mexico, United Kingdom and the Ukraine. Rich Lavin, CVG’s President & CEO, accepted the award and delivered the keynote address at the Hilton in downtown Columbus. “It is an honor to accept the award for 2015 International Company of the Year on behalf of Commercial Vehicle Group”, said Lavin. “We look forward to the opportunity to continue our global outreach efforts with the local community and the Columbus Council on World Affairs as they address key global issues such as education, sustainability, technology, foreign affairs and global trade”.

Patrick Terrien, President & CEO of the Columbus Council on World Affairs stated, “CVG is one of our region’s hidden gems – its global experience and reach are examples of how local companies can stay competitive by leveraging overseas markets. The Columbus Council on World Affairs is proud to honor CVG as the 2015 International Company of the Year.”

Past Company honorees include American Electric Power, Battelle, Cardinal Health, CAS, the City of Columbus,Columbus Crew, Greif, Honda, Limited Brands, Nationwide, and The Ohio State University.

About Commercial Vehicle Group, Inc.
Commercial Vehicle Group, Inc. is a Delaware (USA) corporation. We were formed as a privately-held company in August 2000. We became a publicly held company in 2004. The Company (and its subsidiaries) is a leading supplier of a full range of cab related products and systems for the global commercial vehicle market, including the medium-and heavy-duty truck market, the medium-and heavy-construction vehicle markets, the military, bus, agriculture, specialty transportation, mining, industrial equipment and off-road recreational (ATV/UTV) markets. Information about the Company and its products is available on the internet at

About the Columbus Council on World Affairs
Since 1975, the Columbus Council on World Affairs has increased global awareness in our region. The CCWA fosters a community that is well-informed about critical international issues as they affect the world, nation and the local region. Columbus citizens then utilize this insight to make effective decisions in our global society. To learn more, go to

Source: Commercial Vehicle Group, Inc.
Related Links:

Written by asiafreshnews

March 11, 2015 at 3:10 pm

Posted in Uncategorized

Avnet Broadens Reach of X-fest Technical Training with New On-Demand Videos

leave a comment »

SINGAPORE /PRNewswire/ — Between September 2014 and January 2015, more than 6,000 engineers worldwide, including 4,000 engineers from Asia, attended Avnet’s 37-city X-fest technical seminar series to receive expert instruction on designing with the Xilinx® 7 series, Zynq®-7000 All Programmable SoC and UltraScale™ device families.

Avnet Electronics Marketing Asia, an operating group of Avnet, Inc. (NYSE: AVT) is making these technical workshops available to an even broader audience with the launch of the 2014 X-fest On Demand website today onwards. The site offers viewers free, unlimited access to video recordings of all 12 instructional courses offered throughout the X-fest series. The post-event site also includes descriptions of the exhibits and product demonstrations featured at the live X-fest events.

This year’s X-fest program featured twelve technical courses based on the Xilinx® 7 series, Zynq® -7000 All Programmable SoC and UltraScale™ device families. Now, on demand, viewers can watch presentations from any of the three educational tracks: Zynq Applications, FPGA/SoC Design Techniques and Zynq System Design. The courses were developed and presented by Avnet FAEs and technical experts in collaboration with leading suppliers including Xilinx, Inc., Analog Devices, Inc., STMicroelectronics, TE Connectivity (TE), Texas Instruments Inc., Maxim Integrated Products Inc., Micron Technology, Inc. and Freescale Semiconductor, Inc.

“As much as attendees are able to take away from these workshops, we know that it’s a lot of information to digest in just one day,” said Tim Barber, senior vice president, design chain business development, Avnet Electronics Marketing. “By making these videos available online, those who attended the event can get a convenient refresher and also view presentations that they missed. And, of course, those that could not be present for any of the live events can now take advantage of the online offerings to boost their understanding of these key technologies.”

“As a lead sponsor for X-fest 2014, Xilinx worked closely with Avnet to deploy this very successful X-fest program,” said Chris Henry, vice president, sales operations and channel sales, Xilinx. “X-fest is already a great vehicle for thousands of design engineers to expand their knowledge of Xilinx’s All Programmable devices. We are very pleased Avnet has made this content available online for post-event review for those engineers who were unable to participate live, and those who would like to refresh their knowledge gained from the event.”

To view full course descriptions and access the on-demand videos, visit the 2014 X-fest On Demand website.

About Avnet Electronics Marketing Asia

Avnet Electronics Marketing, an operating group of Avnet, Inc. (NYSE: AVT), is the leading electronics component distributor in Asia. With its regional headquarters in Singapore, the company has offices in 47 locations in Asia. Avnet Electronics Marketing Asia distributes semiconductors, interconnects, passive and electromechanical components to serve a wide range of customers including original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and small- to medium-sized businesses, and provides associated design-chain and supply-chain services. More information is available at

About Avnet
Avnet, Inc. (NYSE: AVT), a Fortune 500 company, is one of the largest distributors of electronic components, computer products and embedded technology serving customers globally. Avnet accelerates its partners’ success by connecting the world’s leading technology suppliers with a broad base of customers by providing cost-effective, value-added services and solutions. For the fiscal year ended June 28, 2014, Avnet generated revenue of $27.5 billion. For more information, visit

WeChat ID: AvnetAsia
Join Avnet’s LinkedIn community
Read more about Avnet on our blog

Tan Weiwei
Avnet Electronics Marketing Asia

Source: Avnet Electronics Marketing Asia

Related stocks: NYSE:AVT

Written by asiafreshnews

March 11, 2015 at 3:07 pm

Posted in Uncategorized